MarketScreener Strategies NFL Biosciences

Stocks

Real-time Euronext Paris 08:26:43 01/10/2026 BST			5-day change	1st Jan Change
0.6910 ^EUR	+0.14%		-8.48%	-41.34%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI